Have you or your loved ones been diagnosed with advanced solid neoplasms?

You may be eligible to participate in a advanced solid neoplasms clinical trial.

Have you or your loved ones been diagnosed with advanced solid neoplasms? You may be eligible to participate in a advanced solid neoplasms clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Neoplasms Clinical Trial
NCT02829099 | Phase 1 | Interventional

Have you or your loved ones been diagnosed with advanced solid neoplasms?

You may be eligible to participate in a advanced solid neoplasms clinical trial.

Have you or your loved ones been diagnosed with advanced solid neoplasms? You may be eligible to participate in a advanced solid neoplasms clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 95 Participants

The primary purpose of the study is to determine the recommended Phase 2 dose (RP2D) and schedule of JNJ-64457107 when administered intravenously (IV) to participants with advanced stage solid tumors in Part 1 and to further characterize the safety of JNJ-64457107 when administered IV to participants with non-small cell lung cancer (NSCLC), pancreatic cancer and cutaneous melanoma in Part 2.